OncoMatch/Clinical Trials/NCT07881133

Perioperative Biomarkers in Colorectal and Gastric Cancer Surgery

Official title: Temporal Profiles of Inflammatory Markers in General Oncologic Surgery

Is NCT07881133 recruiting? Yes, currently enrolling (Oct 2026). This NA trial studies non-drug interventions for colorectal (colon or rectal) cancer.

This study aims to evaluate whether monitoring perioperative inflammatory and metabolic biomarkers can help identify postoperative complications early in adult patients undergoing colorectal or gastric cancer surgery. The study is a randomized controlled trial conducted at Bucharest Emergency Clinical Hospital, Romania. Participants are assigned to either an intervention group receiving enhanced recovery care (ERAS) combined with perioperative biomarker monitoring or a control group receiving standard postoperative care. The biomarkers of interest include procalcitonin, lactate, and blood glucose. The study will examine their relationship with postoperative complications, particularly infections and anastomotic leakage. Participants will be followed for 30 days after surgery to assess postoperative complications, hospital length of stay, readmissions, and mortality. The findings may help improve postoperative monitoring and support earlier recognition of complications in patients undergoing cancer surgery.